Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clinton F Stewart

Showing results (131-140 of 220) with videos related to

Pageof 22
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 12, 2004
Phase I trial of temozolomide and protracted irinotecan in pediatric patients with refractory solid tumorsLars M Wagner, Kristine R Crews, Lisa C Iacono, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2002
Protracted intermittent schedule of topotecan in children with refractory acute leukemia: a pediatric oncology group studyWayne L Furman, Clinton F Stewart, Mark Kirstein, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 19, 2008
Phase I clinical trial of cilengitide in children with refractory brain tumors: Pediatric Brain Tumor Consortium Study PBTC-012Tobey J MacDonald, Clinton F Stewart, Mehmet Kocak, et al.
Pediatric Nephrology (Berlin, Germany)|April 23, 2025
Comparison of GFR estimation equations using creatinine, cystatin C, and their combination in pediatric hematology-oncology: no single equation is superior across subgroupsKatelyn J Phillips, Yilun Sun, Li Tang, et al.
Pediatric Blood & Cancer|January 30, 2015
Comparable efficacy with varying dosages of glucarpidase in pediatric oncology patientsJeffrey R Scott, Yinmei Zhou, Cheng Cheng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 4, 2007
Bevacizumab-induced transient remodeling of the vasculature in neuroblastoma xenografts results in improved delivery and efficacy of systemically administered chemotherapyPaxton V Dickson, John B Hamner, Thomas L Sims, et al.
Cancer Research|July 23, 2015
ABCG2 Transporter Expression Impacts Group 3 Medulloblastoma Response to ChemotherapyMarie Morfouace, Satish Cheepala, Sadhana Jackson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2007
Phase I study of everolimus in pediatric patients with refractory solid tumorsMaryam Fouladi, Fred Laningham, Jianrong Wu, et al.
Journal of Neuro-Oncology|November 1, 2015
Preclinical studies of 5-fluoro-2'-deoxycytidine and tetrahydrouridine in pediatric brain tumorsMarie Morfouace, Birgit Nimmervoll, Nidal Boulos, et al.
Scientific Reports|August 15, 2024
Entinostat as a combinatorial therapeutic for rhabdomyosarcomaShefali Chauhan, Emily Lian, Iman Habib, et al.
Pageof 22

Showing results (131-140 of 220) with videos related to

Sort By:
Pageof 22
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 12, 2004
Phase I trial of temozolomide and protracted irinotecan in pediatric patients with refractory solid tumorsLars M Wagner, Kristine R Crews, Lisa C Iacono, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2002
Protracted intermittent schedule of topotecan in children with refractory acute leukemia: a pediatric oncology group studyWayne L Furman, Clinton F Stewart, Mark Kirstein, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 19, 2008
Phase I clinical trial of cilengitide in children with refractory brain tumors: Pediatric Brain Tumor Consortium Study PBTC-012Tobey J MacDonald, Clinton F Stewart, Mehmet Kocak, et al.
Pediatric Nephrology (Berlin, Germany)|April 23, 2025
Comparison of GFR estimation equations using creatinine, cystatin C, and their combination in pediatric hematology-oncology: no single equation is superior across subgroupsKatelyn J Phillips, Yilun Sun, Li Tang, et al.
Pediatric Blood & Cancer|January 30, 2015
Comparable efficacy with varying dosages of glucarpidase in pediatric oncology patientsJeffrey R Scott, Yinmei Zhou, Cheng Cheng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 4, 2007
Bevacizumab-induced transient remodeling of the vasculature in neuroblastoma xenografts results in improved delivery and efficacy of systemically administered chemotherapyPaxton V Dickson, John B Hamner, Thomas L Sims, et al.
Cancer Research|July 23, 2015
ABCG2 Transporter Expression Impacts Group 3 Medulloblastoma Response to ChemotherapyMarie Morfouace, Satish Cheepala, Sadhana Jackson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2007
Phase I study of everolimus in pediatric patients with refractory solid tumorsMaryam Fouladi, Fred Laningham, Jianrong Wu, et al.
Journal of Neuro-Oncology|November 1, 2015
Preclinical studies of 5-fluoro-2'-deoxycytidine and tetrahydrouridine in pediatric brain tumorsMarie Morfouace, Birgit Nimmervoll, Nidal Boulos, et al.
Scientific Reports|August 15, 2024
Entinostat as a combinatorial therapeutic for rhabdomyosarcomaShefali Chauhan, Emily Lian, Iman Habib, et al.
Pageof 22